High expression of TRIM44 was less frequent in squamous cell carcinoma (SCC) cases than in adenocarcinoma (ADC) cases (52.3% vs. 72.2%, respectively; P < 0.001; Table 1). This evidence concerns the gene TRIM44 and adenocarcinoma.